Count | |
| 10 | |
| 7 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 13 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
Captopril/administration & dosage/*adverse effects/therapeutic use | 1 |
Captopril/*administration & dosage/adverse effects/therapeutic use | 1 |
Captopril/administration & dosage/adverse effects/*therapeutic use | 1 |
| 1 | |
| 1 | |
| 10 | |
| 39 | |
| 19 | |
| 1 | |
| 39 | |
| 56 | |
| 4 | |
| 1 | |
| 3 | |
| 6 | |
| 3 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 5 | |
| 1 | |
| 1 | |
| 1 | |
| 7 | |
| 1 | |
| 1 | |
Captopril/administration & dosage/pharmacology/*therapeutic use | 2 |
Captopril/*analogs & derivatives/pharmacology/therapeutic use | 1 |
Captopril/administration & dosage/pharmacology/therapeutic use | 2 |
Captopril/administration & dosage/*analogs & derivatives/therapeutic use | 1 |
Arginine/adverse effects/*analogs & derivatives/blood/*drug effects | 1 |
C-Reactive Protein/adverse effects/*drug effects/*metabolism | 1 |
Phosphoproteins/adverse effects/*antagonists & inhibitors/drug effects | 1 |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 2 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 10 | |
| 6 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 2 | |
| 3 | |
| 1 | |
| 5 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 5 | |
| 5 | |
| 1 | |
| 7 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 2 | |
| 3 | |
| 9 | |
| 1 | |